Zyxin Is a Transforming Growth Factor-β (TGF-β)/Smad3 Target Gene That Regulates Lung Cancer Cell Motility via Integrin α5β1

Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma

(2012) S. P. Malkoski et al.   CLINICAL CANCER RESEARCH

Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells

(2011) Y-P Yu et al.   ONCOGENE

High Throughput Determination of TGFβ1/SMAD3 Targets in A549 Lung Epithelial Cells

(2011) Yingze Zhang et al.   PLoS One

Transforming growth factor-β and the hallmarks of cancer

(2010) Maozhen Tian et al.   CELLULAR SIGNALLING

Transforming growth factor-beta signaling and tumor angiogenesis

(2010) Evangelia Pardali   Frontiers in Bioscience-Landmark

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Smad3 Protein Levels Are Modulated by Ras Activity and during the Cell Cycle to Dictate Transforming Growth Factor-β Responses

(2009) Amanda C. Daly et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Zyxin Mediates Actin Fiber Reorganization in Epithelial–Mesenchymal Transition and Contributes to Endocardial Morphogenesis

(2009) Masaki Mori et al.   MOLECULAR BIOLOGY OF THE CELL

Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility

(2009) Silvia Giampieri et al.   NATURE CELL BIOLOGY